EUVIMEDEUVIMED entdecken
Crossref

L26/P-528 A personalized functional assay using patient-derived endometrial organoids and blastoids to predict frozen embryo transfer outcomes

E. Tjahjono, M. Kaye, G.M. Grunert, M. Pingle, S. Novich, Y. Katz, A. Warmflash

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E. Tjahjono und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can a personalized assay combining patient-derived endometrial organoids with stem cell-based blastoids predict frozen embryo transfer (FET) outcomes after IVF? Summary answer Metrics based on imaging of the interface between organoids and blastoids and measurements of hCG from the culture media were both predictive of FET outcomes. What is known already Advances in embryo grading and genetic testing have improved frozen embryo transfer outcomes, yet many transfers with euploid embryos still fail. Successful implantation requires interaction between embryo and endometrium, but reliable tests for endometrial receptivity are lacking. Current tests based on endometrial gene expression have shown limited success in predicting implantation windows or transfer outcomes. Endometrial organoids represent personalized tissue models that can be maintained indefinitely in culture, while blastoids provide standardized embryo models for studying implantation processes. Study design, size, duration Prospective observational study collecting endometrial biopsies from over 100 patients preparing for FET. Patient-derived organoids were combined with blastoids to create a functional implantation assay. hCG measurements and confocal imaging of blastoid-organoid integration were compared with patient clinical histories and prospective FET outcomes. Participants/materials, setting, methods Endometrial organoids were established from patient biopsies and grown on micropatterned substrates for standardization. Blastoids were generated from RFP-labeled naive human pluripotent stem cells. Organoids were primed with estrogen and progesterone before blastoid introduction. Confocal imaging assessed blastoid-organoid invasion using RFP together with MUC1, phalloidin, and DAPI staining. hCG concentrations were measured from culture media. Invasion was manually scored and combined with hCG data. Main results and the role of chance hCG levels decreased with increasing implantation failure history, with patients having ≥3 failures showing uniformly low production (p = 0.012, Student’s t-test). Binarizing hCG data revealed ∼10% success rates in the low hCG group versus 65% in the high hCG group (p = 0.006, Fisher’s exact test). Imaging of blastoid-organoid invasion correlated with hCG (Pearson r = 0.51) but provided independent information, with high-invasion patients showing significantly better outcomes (p = 0.004, Fisher’s exact test). Combining both metrics, patients with high hCG and high invasion achieved 82% success (n = 39), those with either low hCG or low invasion showed 60% success (n = 51), and strikingly, none of the patients with both low hCG and low invasion achieved success (n = 6). Comparisons were highly significant: high hCG/high invasion vs mixed (p = 0.006), high hCG/high invasion vs both low (p = 0.0002), and mixed vs both low (p = 0.037, Fisher’s exact tests). Limitations, reasons for caution This assay requires further validation in larger prospective cohorts. Clinical utility for guiding treatment decisions needs evaluation in randomized trials. Wider implications of the findings This functional stem cell-based assay offers a novel approach to personalized assessment of endometrial receptivity. Combining hCG and imaging metrics may enable identification of patients with implantation dysfunction and guide treatment optimization, potentially improving IVF success rates. Trial registration number No

Zitieren

APA

Tjahjono, E., Kaye, M., Grunert, G., Pingle, M., Novich, S., Katz, Y., & Warmflash, A. (2026). L26/P-528 A personalized functional assay using patient-derived endometrial organoids and blastoids to predict frozen embryo transfer outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.861

Vancouver

Tjahjono E, Kaye M, Grunert G, Pingle M, Novich S, Katz Y, et al. L26/P-528 A personalized functional assay using patient-derived endometrial organoids and blastoids to predict frozen embryo transfer outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.861

BibTeX
@article{Tjahjono2026,
  author = {Tjahjono, E. and Kaye, M. and Grunert, G.M. and Pingle, M. and Novich, S. and Katz, Y. and Warmflash, A.},
  title = {L26/P-528 A personalized functional assay using patient-derived endometrial organoids and blastoids to predict frozen embryo transfer outcomes},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.861}
}
Kostenlos starten →